Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Susan E CohnMargaret Chesney

Abstract

High-level adherence to regimens of combination antiretroviral therapy and prophylactic medications for opportunistic infections (OIs) is crucial to their success. However, little is known about the association between adherence to these life-sustaining therapies and such clinical outcomes as progression of acquired immune deficiency syndrome (AIDS) or development of OIs. We assessed adherence to regimens of antiretroviral and Mycobacterium avium complex (MAC) prophylactic medications in 643 patients enrolled in a trial of MAC prophylaxis. By week 56 of the study follow-up, 42% of the patients reported nonadherence to MAC prophylaxis, whereas one-quarter of the patients reported nonadherence to potent antiretroviral regimens. Nonadherence to both MAC prophylaxis and antiretroviral therapy was associated with higher human immunodeficiency virus (HIV) type 1 RNA levels and a significant increase in the risk of developing an AIDS-defining complication or death. Predictors of nonadherence are presented. These results underscore the clinical significance of adherence to HIV therapy and may be helpful in designing interventions to optimize the management of HIV by improving adherence.

References

Jun 24, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·L J EldredR D Moore
Dec 24, 1998·The New England Journal of Medicine·S A BozzetteM F Shapiro
Jul 1, 1999·JAMA : the Journal of the American Medical Association·M F ShapiroS A Bozzette
Jul 31, 1999·Journal of Acquired Immune Deficiency Syndromes : JAIDS·H PalacioR M Greenblatt
Jun 24, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A L GiffordS A Bozzette
Jul 6, 2000·Annals of Internal Medicine·D L PatersonN Singh
Mar 20, 2001·JAMA : the Journal of the American Medical Association·S L HaderS D Holmberg
May 16, 2001·Annals of Internal Medicine·H LiuN S Wenger
Sep 11, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H ArnstenE E Schoenbaum
Oct 2, 2001·AIDS·J E KaplanUNKNOWN Adult and Adolescent Spectrum of HIV Disease Project Investigators

❮ Previous
Next ❯

Citations

Mar 2, 2005·AIDS Care·K K UldallUNKNOWN HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group
Apr 20, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E KaplanH Watts
Jul 27, 2007·AIDS Patient Care and STDs·Ravi A MadanLisa L Dever
Mar 31, 2009·AIDS Patient Care and STDs·Priscilla S DlaminiWilliam L Holzemer
Nov 5, 2011·BMC Medical Research Methodology·Sara GarfieldAlan Willson
May 19, 2006·Nursing Research·William L HolzemerJoseph T Mullan
Feb 23, 2008·AIDS Care·S MannheimerUNKNOWN Terry Beirn Community Program for Clinical Research on AIDS
Nov 21, 2014·The Cochrane Database of Systematic Reviews·Robby NieuwlaatR Brian Haynes
Aug 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Stephen P RaffantiUNKNOWN Collaborations in HIV Outcomes Research/United States Project
Apr 22, 2008·The Cochrane Database of Systematic Reviews·R B HaynesX Yao
Feb 22, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·M Rosa SolorioWilliam Cunningham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Paulo F BarrosoLee H Harrison
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J S Currier
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Choi Fung HoKa Hing Wong
The Journal of the Association of Nurses in AIDS Care : JANAC
Carolyn J SaviniDaniel J DiGuglielmo
© 2022 Meta ULC. All rights reserved